FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

Your Health

Postmenopausal osteoporosis is a significant and women's health issue that far too often gets overlooked, despite being common. One in two women will experience a fracture due to osteoporosis in her lifetime, and these fractures can be devastating, with many leading to hospital stays and life-altering consequences.


A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

CLICK HERE To learn more about this new treatment option.

ADVERTISEMENT

New White Paper Seeks to Improve Maternal Immunization Rates

HealthyWoman among numerous prominent organizations addressing maternal immunization rates

Policy

Sex Trafficking Isn’t What You Think: 4 Myths Debunked – and 1 Real-World Way to Prevent Sexual Exploitation

Trafficking victims are often younger transgender people or teens experiencing homelessness who exchange sex with others to meet their basic needs

Policy

by eMediHealth

☆☆☆☆☆ By eMediHealth ☆☆☆☆☆